EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Progranulin promotes glioma progression via interaction with cathepsin D and serves as a diagnostic and prognostic biomarker

Chunming Zhao, Jiamei Guo, Zhong Zhou, Xulong Huang, Yifan Hai, Wenbo Gao, Chaohang Chen, Guokai Dong, Hongxing Cai, Shanshan Li

Discover Oncology · 27.01.2026 · 17 (1)

DOI: 10.1007/s12672-026-04529-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 27.01.2026. Verfasst von Chunming Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy, Xuzhou Medical University, Xuzhou, Jiangsu, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postgraduate Research & Practice Innovation Program of Jiangsu Province, National Natural Science Foundation of China, National Demonstration Center for Experimental Basic Medical Science Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progranulin (PGRN) plays a crucial role in the progression of various tumor types, making it a potentially valuable biomarker. However, the roles of PGRN vary across tumor types. Therefore, this study aimed to comprehensively analyze PGRN expression in different tumor types to better understand and apply biomarker-guided cancer therapy. The pan-cancer data were obtained from the University of California Santa Cruz Xena platform, and PGRN expression was extensively examined across various cancer types and the corresponding normal tissues. R packages were used for data analysis, including survival outcomes, baseline characteristic assessments, and univariate and multivariate Cox regression models to evaluate the prognostic significance of PGRN. Quantitative real-time polymerase chain reaction (qPCR), co-immunoprecipitation assay, and immunoblotting were performed for molecular interaction and expression. Real-time cell analysis and migration and invasion assays were conducted for phenotype examination. Results showed that PGRN promotes glioma cell proliferation, migration, and invasion. It also interacts with precursor cathepsin D (CTSD) and facilitates its maturation, thereby linking PGRN’s tumor-promoting effects to CTSD. PGRN can be used as a diagnostic and prognostic biomarker for gliomas. Our study offers a foundational framework for using PGRN in glioma diagnosis and prognosis. The potential of PGRN as both a diagnostic and prognostic biomarker was identified suggesting novel avenues for targeted therapeutic strategies in glioma management. Graphical abstract

Schlagwörter

Stichwörter der Autor:innen

Cathepsin DGliomaPrognosisProgranulinsTumor biomarker

Autor:innen und Institutionen

  • Department of Human Anatomy, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Jiangsu Medical Engineering Research Center of Gene Detection, Xuzhou, Jiangsu, China.
  • Judicial Expertise Office, Jiaxing University, Jiaxing, Zhejiang,, China.
  • Department of Forensic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • The First Clinical Medical College, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Jiangsu Medical Engineering Research Center of Gene Detection, Xuzhou, Jiangsu, China. sharon6128126@xzhmu.edu.cn.

Förderung

  • Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • National Natural Science Foundation of China
  • National Demonstration Center for Experimental Basic Medical Science Education

Zitieren

APA

Zhao, C., Guo, J., Zhou, Z., Huang, X., Hai, Y., Gao, W., Chen, C., Dong, G., Cai, H., & Li, S. (2026). Progranulin promotes glioma progression via interaction with cathepsin D and serves as a diagnostic and prognostic biomarker. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-04529-9

Vancouver

Zhao C, Guo J, Zhou Z, Huang X, Hai Y, Gao W, et al. Progranulin promotes glioma progression via interaction with cathepsin D and serves as a diagnostic and prognostic biomarker. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-04529-9

BibTeX
@article{Zhao2026,
  author = {Zhao, Chunming and Guo, Jiamei and Zhou, Zhong and Huang, Xulong and Hai, Yifan and Gao, Wenbo and Chen, Chaohang and Dong, Guokai and Cai, Hongxing and Li, Shanshan},
  title = {Progranulin promotes glioma progression via interaction with cathepsin D and serves as a diagnostic and prognostic biomarker},
  journal = {Discover Oncology},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.1007/s12672-026-04529-9}
}
Kostenlos starten →